Respiratory
Conditions
Interventions
Phenotype Asthma Management
GINA Based Asthma Management
Sponsors
UNTH Enugu
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Children and adolescents aged 6 to 17 years Physician-diagnosed asthma for at least 6 months Stable clinical condition at enrollment (no acute exacerbation within the past 2 weeks) Ability to attend three scheduled clinic visits over a 12-month period Parent or guardian able to provide written informed consent Child able to provide assent, where applicable Resident within the study catchment area for the duration of follow-up Willingness to comply with study procedures and follow-up schedule
Exclusion criteria
Exclusion criteria: Children with other chronic respiratory conditions (e.g., cystic fibrosis, bronchiectasis) History of congenital heart disease or other significant cardiac pathology Presence of immunodeficiency or chronic systemic illness Acute asthma exacerbation within the past 2 weeks Use of systemic corticosteroids within the past 4 weeks Inability to perform spirometry or complete study assessments Planned relocation or inability to complete 12-month follow-up Refusal or inability to provide informed consent or assent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Asthma control status at 12 months, measured using the GINA asthma control tool (categorized as well-controlled, partly controlled, or uncontrolled).;Change in Health Belief Model (HBM) constructs, including perceived severity, susceptibility, benefits, barriers, cues to action, and self-efficacy — assessed via structured caregiver questionnaire at baseline, 6 weeks, and 12 months;Outcome Time Points Clarification -Day 0 (Baseline Visit): Pre-intervention — This visit includes enrollment, eligibility confirmation, and collection of baseline data (spirometry, IgE testing, skin prick test, and questionnaires: C-ACT, PAQLQ, MAQ, HBM). These assessments serve as the pre-intervention reference. Immediately after data collection, the intervention begins primarily consisting of tailored asthma education and reinforcement of individualized management strategies based on group assignment. 6 Weeks (Mid-point Visit): During intervention — Follow-up assessment to monitor early treatment response, reinforce education, adjust medications if needed, and re-administer selected questionnaires. 12 Months (Final Visit): *Post-intervention* — Final evaluation of asthma control, quality of life, and adherence after sustained treatment. Repeat spirometry and all questionnaires to assess long-term outcomes. | — |
Secondary
| Measure | Time frame |
|---|---|
| Frequency of asthma exacerbations over the 12-month follow-up period ;School absenteeism due to asthma symptoms ;Emergency room visits or hospitalizations for asthma-related events ;Changes in spirometry parameters (FEV1, FVC) between baseline and final visit Medication adherence, assessed via caregiver report and clinic documentation ;Quality of life, measured using a validated pediatric asthma questionnaire | — |
Countries
Nigeria
Contacts
Public ContactCynthia Emeworo
Nurse study coordinator LLA ENUGU
Outcome results
None listed